ARTICLE | Clinical News
Chondrogel: Completed Phase III trial enrollment
September 25, 2000 7:00 AM UTC
Curis Inc. (CRIS), Cambridge, Mass. Product: Chondrogel Business: Biomaterial/Skin/Wound Therapeutic category: Cell replacement Target: NA Description: Autologous cultured cartilage cells Indication: ...